Takeshi Saika
About
In The Last Decade
Takeshi Saika
53 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Microbiology 885
- Physiology 452
- Epidemiology 274
- Public Health, Environmental and Occupational Health 154
- Infectious Diseases 132
Countries citing papers authored by Takeshi Saika
This map shows the geographic impact of Takeshi Saika's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Saika with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Saika more than expected).
Fields of papers citing papers by Takeshi Saika
This network shows the impact of papers produced by Takeshi Saika. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Saika. The network helps show where Takeshi Saika may publish in the future.
Co-authorship network of co-authors of Takeshi Saika
This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Saika. A scholar is included among the top collaborators of Takeshi Saika based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Saika. Takeshi Saika is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone breakdown → | 517 |
| 3 | 25 | |
| 4 | 83 | |
| 5 | 27 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 22 | |
| 10 | 6 | |
| 11 | Relationship between clarithromycin breakpoint for Hericobacter pylori and point mutation in 23SrRNA gene | 1 |
| 12 | 6 | |
| 13 | 1 | |
| 14 | A mouse model of Escherichia coli .O157: H7 infection for evaluation of antibacterial drugs - In vivo release of verotoxins and toxic effect on mice | 3 |
| 15 | 2 | |
| 16 | 10 | |
| 17 | 2 | |
| 18 | In vitro activities of tosufloxacin and five quinolones against 1,112 bacterial clinical isolates. | 2 |
| 19 | 1 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.